Evidence map›Paper›PMID 40585714›Full record

ArticleCureus2025

Predictors of Gallstones in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Uzma Soomro, Ghulam Abbas, Muhammad Aslam, Sanjay Kirshan Kumar, Syed Mudassir Laeeq, Ali Hyder, Raja Taha Yaseen Khan, Nasir Hassan Luck

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Uzma SoomroGeneral Surgery, Sindh Institute of Medical Sciences, Karachi, PAK.
Ghulam AbbasGastroenterology and Hepatology, Allama Iqbal Medical College, Lahore, PAK.
Muhammad AslamGastroenterology, Madina Teaching Hospital, Faislabad, PAK.
Sanjay Kirshan KumarGastroenterology, Ahalia Hospital, Abu Dhabi, ARE.
Syed Mudassir LaeeqHepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, PAK.
Ali HyderGastroenterology, Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, PAK.
Raja Taha Yaseen KhanHepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, PAK.
Nasir Hassan LuckHepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Metabolic dysfunction-associated fatty liver disease (MAFLD) has become the most prevalent chronic liver disease worldwide, particularly in South Asian countries like Pakistan. Gallstone disease (GSD), often associated with metabolic abnormalities, shares several risk factors with MAFLD, such as obesity, diabetes, and dyslipidemia. Despite international evidence supporting an association between MAFLD and GSD, there is a hdlscarcity of local data in this regard. Therefore, this study aimed to determine the independent predictors of GSD in MAFLD patients in Pakistan. Study methodology This cross-sectional study was conducted at the Hepatogastroenterology Department of Sindh Institute of Urology and Transplantation (SIUT) from January to December 2024. A total of 350 adults with the presence of fatty liver on ultrasound were enrolled. Patients with significant alcohol intake, those with known liver diseases, prior cholecystectomy, pregnancy, and use of lipid-altering medications were excluded from the study. Demographic, clinical, and laboratory parameters were recorded. Gallbladder stones were identified using abdominal ultrasound. Univariate analysis followed by multivariate logistic regression was performed to identify the independent predictors of GSD. Results Among 350 patients with MAFLD, 102 (29.1%) had gallstones. Patients with gallstones were significantly older (mean age 52.1 vs. 47.1 years, p<0.001), with a higher prevalence of female gender (63.7% vs. 35.4%, p<0.001) and diabetes mellitus (68.6% vs. 48.3%, p = 0.002). Laboratory markers including alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total cholesterol, triglycerides, and fasting blood sugar (FBS) were significantly elevated in the gallstone group, whereas high-density lipoprotein (HDL) was significantly lower. Multivariate logistic regression identified increasing age (OR 1.04), female gender (OR 2.73), diabetes mellitus (OR 1.89), elevated ALP (OR 1.02), low HDL (OR 1.76), and elevated FBS (OR 1.31) as independent predictors of gallstones in MAFLD. Conclusion In this study, 29.1% of MAFLD patients had GSD. Older age, female gender, diabetes, elevated ALP, low HDL, and high FBS were the factors independently associated with the presence of GSD in MAFLD. Further multi-centered prospective studies incorporating dietary, hormonal, and genetic factors are required for the validation of these results.

Indexed as

diabetes mellitusgallstonesnon-alcoholic fatty liver diseasepakistanpredictors

Identifiers

PMID40585714
PMCPMC12206348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.